Media

16 November | 2022

Spinal Stabilization Technologies (SST) has begun its LOPAIN2 clinical trial, measuring the efficacy of the PerQdisc Nucleus Replacement Device (NRD)....read more

15 November | 2022

Spinal Stabilization Technologies, Ltd. (SST), Kilkenny, Ireland Spinal Stabilization Technologies (SST) has announced the start of the LOPAIN2 clinical trial of the PerQdisc™ Nucleus Replacement Device (NRD)....read more

27 December | 2021

The spine can be considered the human body’s suspension system, where the intervertebral discs act as shock...read more

7 September | 2021

Spinal Stabilization Technologies and PerQdisc provide a unique solution for nucleus replacement...read more

25 May | 2021

Spinal Stabilization Technologies, Ltd. (SST), Kilkenny, Ireland announced today that it has earned the CE Mark and the FDA's "breakthrough...read more